Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan 13:8:836182.
doi: 10.3389/fmed.2021.836182. eCollection 2021.

Editorial: Management of Sjögren's Syndrome

Alessia Alunno  1 , Clio P Mavragani  2 , Francesco Carubbi  1   3
Affiliations
Editorial

Editorial: Management of Sjögren's Syndrome

Alessia Alunno et al. Front Med (Lausanne). .
No abstract available

Keywords: COVID-19; Sjögren's syndrome; biologic therapies; biomarkers; therapy; ultrasonography.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Management of Sjögren's Syndrome

References

    1. Mariette X, Criswell LA. Primary Sjögren's syndrome. N Engl J Med. (2018) 378:931–9. 10.1056/NEJMcp1702514 - DOI - PubMed
    1. Alunno A, Leone MC, Giacomelli R, Gerli R, Carubbi F. Lymphoma and lymphomagenesis in primary sjögren's syndrome. Front. Med. (2018). 5:102. 10.3389/fmed.2018.00102 - DOI - PMC - PubMed
    1. Seror R, Nocturne G, Mariette X. Current and future therapies for primary Sjögren syndrome. Nat Rev Rheumatol. (2021) 17:475–486. 10.1038/s41584-021-00634-x - DOI - PubMed
    1. Ramos Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, et al. . EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. Ann Rheum Dis. (2020) 79:3–18. 10.1136/annrheumdis-2019-216114 - DOI - PubMed
    1. Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot J-M, Perdriger A, et al. . Severe health-related quality of life impairment in active primary Sjögren's syndrome and patient-reported outcomes: data from a large therapeutic trial. Arthritis Care Res (Hoboken). (2017) 69:528–35. 10.1002/acr.22974 - DOI - PubMed

Publication types

LinkOut - more resources